Zivo Bioscience

Zivo Bioscience EBIT Margin

The EBIT Margin (Operating Margin) of Zivo Bioscience (ZIVO) as of Oct 18, 2026 is -8,278.84 %. In the previous year, EBIT Margin (Operating Margin) was -8,498.85 % — a change of -2.59% (higher).

EBIT Margin

-8,278.84 %

YoY

-2.59%

Last updated:

EBIT Margin (Operating Margin) of Zivo Bioscience is 2025 -8,278.84 % . EBIT Margin (Operating Margin) of Zivo Bioscience was 2024 -8,498.85 % . It decreases by -2.59% higher compared to the previous year.

For Zivo Bioscience, the operating (EBIT) margin of -8,278.8% is up versus -42,778.4% a few years ago.

The Zivo Bioscience EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2011
-18.66 USD
Jan 1, 2013
-11.83 USD
Jan 1, 2019
-41,761.75 USD
Jan 1, 2020
-42,778.38 USD
Jan 1, 2022
-215,604.30 USD
Jan 1, 2023
-26,299.97 USD
Jan 1, 2024
-8,498.85 USD
Jan 1, 2025
-8,278.84 USD
The Zivo Bioscience EBIT Margin history
YEAREBIT MarginYoY
-8,278.84 %-2.59%
-8,498.85 %-67.68%
-26,299.97 %-87.80%
-215,604.30 %+404.00%
-42,778.38 %+2.43%
-41,761.75 %+352,820.81%
-11.83 %-36.58%
-18.66 %-61.99%
-49.09 %+46.43%
-33.52 %+390.12%
-6.84 %-50.61%
-13.85 %+7.26%
-12.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Zivo Bioscience Stock analysis

What does Zivo Bioscience do? Zivo Bioscience Inc., headquartered in Keego Harbor, Michigan, develops and commercializes natural nutritional compounds and bioactive molecules derived from proprietary algal strains. The company focuses on research and development of bioactive ingredients for human and animal dietary supplements, medical foods, and pharmaceutical applications, particularly targeting autoimmune and inflammatory response modulation. With 8 employees, it operates in the Consumer Staples sector, specializing in natural health products and diagnostic testing solutions. Zivo Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zivo Bioscience stock

EBIT Margin (Operating Margin) of Zivo Bioscience is -8,278.84 % in 2025.

EBIT Margin (Operating Margin) of Zivo Bioscience changed from -8,498.85 % to -8,278.84 %, representing a -2.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Zivo Bioscience since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Zivo Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Zivo Bioscience

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Zivo Bioscience